Ngoc Do_Venetoclax plus Obinutuzumab vs Chlorambucil plus Obinutuzumab_Cost-Effectiveness Analysis Model.xlsm

Abstract

The excel model details all the assumptions, data inputs, data sources, and data analysis codes used to output the results represented in our article titled: "Cost-effectiveness of Venetoclax plus Obinutuzumab versus Chlorambucil plus Obinutuzumab for the first-line treatment of adult patients with chronic lymphocytic leukemia - an extended social view." Please see the Data appendix file to view detailed description of the model